State of Alaska Department of Revenue Sells 905 Shares of The Cooper Companies, Inc. $COO

State of Alaska Department of Revenue lowered its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 3.9% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 22,485 shares of the medical device company’s stock after selling 905 shares during the quarter. State of Alaska Department of Revenue’s holdings in Cooper Companies were worth $1,600,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also recently modified their holdings of the company. Zions Bancorporation National Association UT bought a new position in shares of Cooper Companies during the 1st quarter worth approximately $33,000. City Holding Co. bought a new stake in shares of Cooper Companies in the 1st quarter worth approximately $34,000. GKV Capital Management Co. Inc. bought a new stake in shares of Cooper Companies in the 1st quarter worth approximately $40,000. Larson Financial Group LLC raised its holdings in shares of Cooper Companies by 1,071.0% in the 1st quarter. Larson Financial Group LLC now owns 726 shares of the medical device company’s stock worth $61,000 after purchasing an additional 664 shares during the period. Finally, HM Payson & Co. raised its holdings in shares of Cooper Companies by 147.4% in the 1st quarter. HM Payson & Co. now owns 893 shares of the medical device company’s stock worth $75,000 after purchasing an additional 532 shares during the period. Institutional investors own 24.39% of the company’s stock.

Cooper Companies Stock Up 1.9%

COO opened at $70.46 on Friday. The Cooper Companies, Inc. has a one year low of $61.78 and a one year high of $109.37. The company has a debt-to-equity ratio of 0.29, a current ratio of 2.12 and a quick ratio of 1.24. The firm has a market capitalization of $14.01 billion, a P/E ratio of 34.71, a price-to-earnings-growth ratio of 1.81 and a beta of 1.02. The company has a fifty day moving average price of $69.69 and a 200-day moving average price of $74.16.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings data on Wednesday, August 27th. The medical device company reported $1.10 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.07 by $0.03. Cooper Companies had a net margin of 10.08% and a return on equity of 9.82%. The company had revenue of $1.06 billion during the quarter, compared to the consensus estimate of $1.06 billion. During the same period in the previous year, the firm posted $0.96 EPS. The firm’s revenue was up 5.7% compared to the same quarter last year. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. Equities research analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Cooper Companies announced that its board has authorized a stock repurchase program on Wednesday, September 17th that allows the company to repurchase $2.00 billion in shares. This repurchase authorization allows the medical device company to repurchase up to 15.4% of its shares through open market purchases. Shares repurchase programs are usually a sign that the company’s leadership believes its stock is undervalued.

Wall Street Analyst Weigh In

A number of research firms recently commented on COO. JPMorgan Chase & Co. lowered their price target on shares of Cooper Companies from $76.00 to $66.00 and set a “neutral” rating on the stock in a report on Thursday, August 28th. Piper Sandler lowered their price target on shares of Cooper Companies from $105.00 to $83.00 and set an “overweight” rating on the stock in a report on Thursday, August 28th. Wall Street Zen cut shares of Cooper Companies from a “buy” rating to a “hold” rating in a report on Saturday, July 12th. UBS Group raised shares of Cooper Companies to a “buy” rating in a report on Tuesday, June 17th. Finally, Needham & Company LLC reaffirmed a “buy” rating and issued a $94.00 price target on shares of Cooper Companies in a report on Thursday, August 28th. One research analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating, three have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $84.75.

Insider Activity at Cooper Companies

In related news, COO Daniel G. Mcbride acquired 3,000 shares of the company’s stock in a transaction dated Tuesday, September 2nd. The stock was bought at an average cost of $65.04 per share, with a total value of $195,120.00. Following the acquisition, the chief operating officer owned 63,120 shares of the company’s stock, valued at approximately $4,105,324.80. The trade was a 4.99% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Lawrence Erik Kurzius acquired 2,000 shares of the company’s stock in a transaction dated Monday, September 29th. The shares were bought at an average cost of $68.39 per share, with a total value of $136,780.00. Following the completion of the acquisition, the director directly owned 5,777 shares in the company, valued at $395,089.03. The trade was a 52.95% increase in their position. The disclosure for this purchase can be found here. Insiders purchased a total of 17,975 shares of company stock worth $1,216,346 in the last three months. 1.98% of the stock is owned by insiders.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.